(University of California - San Diego) UC San Diego researchers have found a stem cellenzyme copy edits more than 20 tumor types, providing new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.
More From BioPortfolio on "An errant editing enzyme promotes tumor suppressor loss and leukemia propagation"